[Antithrombin III activity in blood of patients with renal cancer].
The activity of antithrombin III (AT III) in the blood of 20 patients with renal carcinoma was examined. An increase of AT III activity in comparison with control group was observed. The increase of AT III activity in the blood of the patients with renal carcinoma can be as a result of compensatory mechanism safing these patients before thromboembolic complication. The measurement of AT III in renal carcinoma can be a prognostic symptom of haemorrhagic and thromboembolic complications.
Zietek
Z
Z
Katedry i Kliniki Urologii, Akademii Medycznej w Bydgoszczy.
Iwan-Zietek
I
I
Kotschy
M
M
Wiśniewska
E
E
Tyloch
F
F
D000328:Adult; D000368:Aged; D000369:Aged, 80 and over; D000990:Antithrombin III / Q000502:physiology*; D002277:Carcinoma / Q000097:blood*; D005260:Female; D006801:Humans; D007680:Kidney Neoplasms / Q000097:blood*; D008297:Male; D008875:Middle Aged
D000990:Antithrombin III